Preclinical studies with new pyrrolidine platinum(II) compounds

Author： Sampedro F.   van Haperen V.R.   Izquierdo M.   Vicens M.   Santalo P.   Pueyo M.   Llagostera M.   Marcuello E.   De Andres L.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.30, Iss.6, 1995-01, pp. : 497-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metallothioneins and Platinum(II) Anti-Tumor Compounds

By  

Current Medicinal Chemistry, Vol. 16, Iss. 5, 2009-02 ,pp. : 522-537

Bentham Science Publishers

Access to resources Recommend Favorite

Platinum(II) and Palladium(II) Complex Compounds as Anti-cancer Drugs. Methods of Cytotoxicity Determination

By  

Current Pharmaceutical Analysis, Vol. 10, Iss. 1, 2014-02 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Studies on Two New Mixed Ligand Platinum Compounds with a Trans- Geometry

By  

Medicinal Chemistry, Vol. 6, Iss. 5, 2010-09 ,pp. : 321-328

Bentham Science Publishers

Access to resources Recommend Favorite

Monofunctional Platinum (PtII) Compounds – Shifting the Paradigm in Designing New Pt-based Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 23, Iss. 12, 2016-05 ,pp. : 1268-1285

Bentham Science Publishers

Access to resources Recommend Favorite

Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 21, 2011-11 ,pp. : 2623-2631

Bentham Science Publishers

Access to resources Recommend Favorite